Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eccles

Showing results (251-260 of 340) with videos related to

Pageof 34
Sort By:
Breast Cancer Research and Treatment|April 17, 2016
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypesKristen S Purrington, Daniel W Visscher, Chen Wang, et al.
American Journal of Human Genetics|April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesA Antoniou, P D P Pharoah, S Narod, et al.
Journal of Medical Genetics|November 14, 2019
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic <i>TP53</i> mutation carriers: a case-controlled study (SIGNIFY)Elizabeth K Bancroft, Sibel Saya, Emma Brown, et al.
British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.
Journal of Medical Genetics|December 28, 2023
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory surveySophie Allen, Lucy Loong, Alice Garrett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
BJU International|June 5, 2024
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriersElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.
Journal of Medical Genetics|August 15, 2012
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer riskAmanda B Spurdle, Phillip J Whiley, Bryony Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
American Journal of Epidemiology|March 28, 2025
Interactions Between Genetic and Epidemiological Factors Influencing Mammographic DensityAustin Hammermeister Suger, Hongjie Chen, Cameron B Haas, et al.
Pageof 34

Showing results (251-260 of 340) with videos related to

Sort By:
Pageof 34
Breast Cancer Research and Treatment|April 17, 2016
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypesKristen S Purrington, Daniel W Visscher, Chen Wang, et al.
American Journal of Human Genetics|April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesA Antoniou, P D P Pharoah, S Narod, et al.
Journal of Medical Genetics|November 14, 2019
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic <i>TP53</i> mutation carriers: a case-controlled study (SIGNIFY)Elizabeth K Bancroft, Sibel Saya, Emma Brown, et al.
British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.
Journal of Medical Genetics|December 28, 2023
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory surveySophie Allen, Lucy Loong, Alice Garrett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
BJU International|June 5, 2024
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriersElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.
Journal of Medical Genetics|August 15, 2012
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer riskAmanda B Spurdle, Phillip J Whiley, Bryony Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
American Journal of Epidemiology|March 28, 2025
Interactions Between Genetic and Epidemiological Factors Influencing Mammographic DensityAustin Hammermeister Suger, Hongjie Chen, Cameron B Haas, et al.
Pageof 34